Serum intact fibroblast growth factor 23 in healthy paediatric population

INTRODUCTION: It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. MATERIAL A...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanczyk, Malgorzata, Chrul, Slawomir, Wyka, Krystyna, Tkaczyk, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262519/
https://www.ncbi.nlm.nih.gov/pubmed/34258392
http://dx.doi.org/10.1515/med-2021-0288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262519/
https://www.ncbi.nlm.nih.gov/pubmed/34258392
http://dx.doi.org/10.1515/med-2021-0288

Ejemplares similares